Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3262765
Max Phase: Preclinical
Molecular Formula: C35H38F3N3O5
Molecular Weight: 637.70
Molecule Type: Small molecule
Associated Items:
ID: ALA3262765
Max Phase: Preclinical
Molecular Formula: C35H38F3N3O5
Molecular Weight: 637.70
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)C[C@@H](NC(=O)c1ccc(C(F)(F)F)cc1)c1ccccc1)C(=O)[C@@]1(C)CO1
Standard InChI: InChI=1S/C35H38F3N3O5/c1-22(2)18-28(31(43)34(3)21-46-34)41-33(45)29(19-23-10-6-4-7-11-23)39-30(42)20-27(24-12-8-5-9-13-24)40-32(44)25-14-16-26(17-15-25)35(36,37)38/h4-17,22,27-29H,18-21H2,1-3H3,(H,39,42)(H,40,44)(H,41,45)/t27-,28+,29+,34-/m1/s1
Standard InChI Key: WMIQZSQGFJUCSD-GXIQWAOMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 637.70 | Molecular Weight (Monoisotopic): 637.2764 | AlogP: 5.18 | #Rotatable Bonds: 14 |
Polar Surface Area: 116.90 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.31 | CX Basic pKa: | CX LogP: 5.89 | CX LogD: 5.89 |
Aromatic Rings: 3 | Heavy Atoms: 46 | QED Weighted: 0.21 | Np Likeness Score: -0.25 |
1. Zhang J, Cao J, Xu L, Zhou Y, Liu T, Li J, Hu Y.. (2014) Design, synthesis and biological evaluation of novel tripeptidyl epoxyketone derivatives constructed from β-amino acid as proteasome inhibitors., 22 (11): [PMID:24767818] [10.1016/j.bmc.2014.04.011] |
Source(1):